StonvexLoading…
StonvexStonvexStonvexCore line items from MCHP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.71B | $3.40B | $2.22B | $1.08B |
Operating Income | $490.10M | $272.70M | $121.00M | $32.10M |
Net Income | $230.00M | $85.80M | $41.70M | $-18.60M |
EPS (Diluted) | $0.22 | $0.00 | $-0.06 | $-0.09 |
Total Assets | $14.37B | $14.33B | $14.47B | $14.98B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $240.30M | $250.70M | $236.80M | $566.50M |
Free Cash Flow OCF − CapEx | $871.00M | $628.20M | $309.30M | $257.70M |
Shares Outstanding | 542.08M | 541.13M | 540.45M | 539.68M |